Bayesian Capital Management’s Alkermes ALKS Stock Holding History

Bayesian Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,074	Closed	-$242K	–	127
2025 Q3	$242K	Buy	+8,074	New	+$228K	0.05%	424
2025 Q2	–	Sell	-13,500	Closed	-$446K	–	526
2025 Q1	$446K	Buy	+13,500	New	+$440K	0.07%	323
2024 Q2	–	Sell	-12,300	Closed	-$333K	–	704
2024 Q1	$333K	Buy	+12,300	New	+$349K	0.03%	533
2023 Q4	–	Sell	-16,400	Closed	-$459K	–	723
2023 Q3	$459K	Buy	+16,400	New	+$481K	0.05%	389
2023 Q2	–	Sell	-14,000	Closed	-$395K	–	771
2023 Q1	$395K	Buy	+14,000	New	+$381K	0.05%	450
2022 Q3	–	Sell	-20,100	Closed	-$599K	–	681
2022 Q2	$599K	Buy	+20,100	New	+$577K	0.11%	281
2020 Q2	–	Sell	-27,172	Closed	-$392K	–	513
2020 Q1	$392K	Buy	27,172 +5,600	+26%	+$100K	0.08%	362
2019 Q4	$440K	Buy	+21,572	New	+$429K	0.08%	332
2019 Q1	–	Sell	-12,406	Closed	-$366K	–	535
2018 Q4	$366K	Buy	12,406 +1,506	+14%	+$55.5K	0.07%	353
2018 Q3	$463K	Buy	+10,900	New	+$473K	0.08%	351
2018 Q2	–	Sell	-4,900	Closed	-$284K	–	582
2018 Q1	$284K	Buy	+4,900	New	+$287K	0.07%	410

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayesian Capital Management's ALKS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 8,074 shares — an estimated $242K sold.

Bayesian Capital Management first reported a position in ALKS in Q1 2018 and held it in 11 quarters. The position peaked at $599K in Q2 2022. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.

Bayesian Capital Management reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 8,074 Alkermes shares in Q4 2025, an estimated $242K.
Bayesian Capital Management first reported a position in Alkermes in Q1 2018 and held it in 11 quarters.
Bayesian Capital Management's Alkermes position peaked at $599K in Q2 2022.
366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.